Learn more about Lindus Health from our blog page. Our posts cover an array of topics from clinical developments to diversity.
Michael Young, Co-CEO of Lindus Health, outlines how digital tools are enabling faster insights, better patient experiences, and smarter outcomes from protocol design to patient follow-up.
The digital transformation of the fertility space has brought us everything from period tracking apps to FDA-cleared digital contraceptives. Yet these tools are often grouped together under broad categories that obscure critical differences in their purpose and effectiveness.
Consumer health is a $6.3 trillion mainstream market with consumers prioritizing solutions that help them feel and look better and live longer. Yet in this crowded, fast-moving space, one principle stands above all others: trust is the foundation of strong consumer health brands.
Ovarian cancer remains one of the most lethal gynecological cancers, largely because diagnosis often comes too late. Around 70% of cases are detected at an advanced stage, with approximately 300,000 new cases each year.
Deciding which trial activities to manage internally and when to engage a diagnostics-focused CRO can significantly impact timelines, data quality, and ultimately, market success.
In oncology diagnostics, selecting between biobank specimens and prospective clinical trials for assay validation is not merely a methodological choice—it’s a strategic imperative.